Evaluating Alternative Cancer Therapies: A Guide to the Science and Politics of an Emerging Medical FieldIn Evaluating Alternative Cancer Therapies, David Hess has interviewed the major opinion leaders in the alternative cancer therapy field - clinicians, researchers, patient advocacy leaders, and journalists - who explain their philosophy of evaluation, their therapeutic preferences, and the political and economic hurdles to getting the necessary research done. Both a guide to the guides and a survey of the field, this innovative book provides a framework for evaluation problems that clinicians and patients face - from patient needs and the quality of potential clinical care givers to research methods, proposed policy reforms, and the therapies themselves. |
Contents
Patrick McGrady Jr | 27 |
Ralph Moss Ph D | 39 |
Susan Silberstein Ph D | 46 |
Frank Wiewel | 57 |
Douglas Brodie M D | 91 |
Michael Culbert D Sc hon | 103 |
W John Diamond M D | 114 |
Robert Houston | 132 |
Cancer Therapies and other publications | 145 |
Morton Walker D P M | 153 |
What the Patient Needs and Which Organizations Will Help | 177 |
Evaluating the Research Methods | 186 |
Glossary and Acronyms | 235 |
Bibliography | 243 |
Common terms and phrases
ACCTs agents alternative and complementary alternative cancer therapies Alternative Medicine alternative therapies American amygdalin anticancer antineoplastons approach assessment bacterial vaccines biological Boik bovine cartilage breast cancer Burzynski cancer patients cancer treatment chemotherapy Chowka clinical trials clinicians Coley's toxins Contreras conventional therapies Culbert cure developed dietary disease doctors doses drugs effects efficacy enzymes Ernesto Contreras Essiac Evaluation Criteria example genistein Gerson therapy going herbal herbs Hildenbrand historical controls hospital Houston Hoxsey hydrazine sulfate immune system interview Journal laetrile Lerner liver macrobiotic diet malignant mechanisms metabolic metastases Michael Lerner modalities Moss National Cancer Institute nontoxic nutritional Oncology organizations outcomes Pelton percent problem protein protocol randomized RCTs remission reports retrospective Revici scientific shark cartilage studies supplements survival tests thera Therapeutic Preferences things tients Tijuana tion toxic treated tumor U.S. Congress vitamin Wiewel